Perspective Therapeutics CATX
NYSE CATX
$1.60 -0.64 (-28.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Cash & Current Investments (2010 - 2026)

Updated

Perspective Therapeutics' Cash & Current Investments came in at $236.9 million for Q2 2026, up 23.6% from $191.6 million a year earlier but down 12.6% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Perspective Therapeutics' Cash & Current Investments was $144.7 million, down 36.2% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 127.2% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $226.9 million in FY2024, $8,000 in FY2023 (-100.0%), $43.76 million in FY2022 and $63.83 million in FY2021.
  • The five-year range for quarterly Cash & Current Investments is $8,000 (Q4 2023) to $292.9 million (Q2 2024).
  • Year-over-year, Cash & Current Investments increased in three of the last six quarters, with an average decline of 6.2%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 934.3%), and the weakest in Q4 2023 (a decline of 100.0%).
  • Business Quant data shows CATX's Cash & Current Investments at $270.9 million (Q1 2026), $144.7 million (Q4 2025) and $174.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Perspective Therapeutics 182.54 Mn -54.36 Mn - 236.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 236.90 Mn
Mar 31, 2026 270.90 Mn
Dec 31, 2025 144.70 Mn
Sep 30, 2025 174.10 Mn
Jun 30, 2025 191.60 Mn
Mar 31, 2025 211.70 Mn
Dec 31, 2024 226.90 Mn
Sep 30, 2024 267.80 Mn
Jun 30, 2024 292.90 Mn
Mar 31, 2024 180.65 Mn
Dec 31, 2023 8,000.00
Sep 30, 2023 17.98 Mn
Jun 30, 2023 28.32 Mn
Mar 31, 2023 36.45 Mn
Dec 31, 2022 43.76 Mn
Sep 30, 2022 54.11 Mn
Jun 30, 2022 55.89 Mn
Mar 31, 2022 58.90 Mn
Dec 31, 2021 60.35 Mn
Sep 30, 2021 61.69 Mn
API Access

Perspective Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CATX&period=max&api_key=YOUR_API_KEY